Article Information
History
- June 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Christian A. Hudert1,
- Anna Alisi2,
- Quentin M. Anstee3,4,
- Annalisa Crudele2,
- Laura G. Draijer5,
- EU-PNAFLD investigators,
- Samuel Furse6,
- Jan G. Hengstler7,
- Benjamin Jenkins6,
- Kylie Karnebeek8,
- Deirdre A. Kelly9,
- Bart G. Koot5,
- Albert Koulman6,
- David Meierhofer10,
- Stuart G. Snowden6,
- Indra van Mourik9,
- Anita Vreugdenhil8,
- Susanna Wiegand11 and
- Jake P. Mann12,*
- 1Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité Universitätsmedizin Berlin, Berlin, Germany
- 2Research Unit of Molecular Genetics of Complex Phenotypes, Bambino Gesù Children’s Hospital-IRCCS, Rome, Italy
- 3Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
- 4Newcastle NIHR Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
- 5Department of Pediatric Gastroenterology and Nutrition, Amsterdam University Medical Center, Emma Children’s Hospital, University of Amsterdam, Netherlands
- 6Core Metabolomics and Lipidomics Laboratory, Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge
- 7Systems Toxicology, Leibniz Research Centre for Working Environment and Human Factors at the Technical University Dortmund, Dortmund, Germany
- 8Center for Overweight Adolescent and Children’s Health Care (COACH), Department of Pediatrics, Maastricht University Medical Center, Maastricht, Netherlands
- 9Liver Unit, Birmingham Women’s and Children’s Hospital Trust, Birmingham, UK
- 10Max Planck Institute for Molecular Genetics, Mass Spectrometry Facility, Berlin, Germany
- 11Center for chronically sick children, Charite Universitätsmedizin Berlin, Berlin, Germany
- 12Institute of Metabolic Science, University of Cambridge, Cambridge, UK
- ↵*Correspondence:
Dr. Jake P Mann, Metabolic Research Laboratories, Level 4, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge, CB2 0QQ, jm2032{at}cam.ac.uk, Tel: +44 1223 336792, Fax: +44 1223 330598
Posted June 07, 2020.
Variants in MARC1 and HSD17B13 reduce severity of NAFLD in children, perturb phospholipid metabolism, and suppress fibrotic pathways
